Harbinger Health is focused on early cancer detection and developing advanced, low-cost multicancer blood tests. Founded in 2021 after three years of incubation within Flagship Pioneering, Harbinger utilizes artificial intelligence and deep biological insights to identify cancer in its earliest, most treatable stages, often before symptoms appear. The organization aims to transform cancer care from a reactionary approach into a proactive model, making early diagnosis a routine part of health management. Committed to principles such as rigor, transparency, inclusiveness, and accountability, Harbinger Health is dedicated to improving patient outcomes and reshaping healthcare systems. The company seeks to attract individuals who are passionate about innovation and collaboration in the health technology sector.